Segments - Adjusted EBITDA by Reportable Segment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA for operating segments	$ (21,436)	$ (17,844)	$ (52,475)
Biopharmaceuticals
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA for operating segments	(45,754)	(35,378)	(44,552)
Exemplar
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA for operating segments	6,898	4,004	(1,586)
Trans Ova
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA for operating segments	17,420	13,530	(2,836)
All Other
Segment Reporting Information [Line Items]
Segment Adjusted EBITDA for operating segments	$ 0	$ 0	$ (3,501)